Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

[1]  N. Mabbott,et al.  Progress in Molecular Biology and Translational Science , 2017 .

[2]  C. Wellington,et al.  High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease. , 2014, Cell metabolism.

[3]  F. Rincon,et al.  Current pathophysiological concepts in cerebral small vessel disease , 2014, Front. Aging Neurosci..

[4]  K. Black,et al.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline. , 2014, The Journal of clinical investigation.

[5]  J. Faber,et al.  Congenic Fine-Mapping Identifies a Major Causal Locus for Variation in the Native Collateral Circulation and Ischemic Injury in Brain and Lower Extremity , 2014, Circulation research.

[6]  B. Zlokovic,et al.  Pericyte loss influences Alzheimer-like neurodegeneration in mice , 2013, Nature Communications.

[7]  Maiken Nedergaard,et al.  Cerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain , 2013, The Journal of Neuroscience.

[8]  Richard Frayne,et al.  Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy , 2013, Neurology.

[9]  J. Vaupel,et al.  Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart , 2013, The Lancet.

[10]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[11]  J. Bond,et al.  A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.

[12]  Daniel J. R. Christensen,et al.  Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.

[13]  N. Pomara,et al.  Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. , 2013, JAMA neurology.

[14]  E. Aronica,et al.  Mouse Models to Study the Effect of Cardiovascular Risk Factors on Brain Structure and Cognition , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[16]  Brian J. Bacskai,et al.  Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models , 2013, Acta Neuropathologica.

[17]  B. Winblad,et al.  Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden , 2013, Neurology.

[18]  J. Faber,et al.  Hypertension and Other Cardiovascular Risk Factors Lead to Premature Rarefaction of the Native Collateral Circulation , 2013 .

[19]  Xiaotang Fan,et al.  LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases , 2013, Molecular Neurobiology.

[20]  B. Zlokovic.  Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. , 2013, JAMA neurology.

[21]  Peter R Luijten,et al.  In Vivo Detection of Cerebral Cortical Microinfarcts with High-Resolution 7T MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  Charles D. Smith,et al.  Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  A. von Eckardstein,et al.  Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling , 2013, Circulation.

[24]  S. Greenberg,et al.  Characteristic distributions of intracerebral hemorrhage–associated diffusion-weighted lesions , 2012, Neurology.

[25]  Tim West,et al.  Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis , 2012, Proceedings of the National Academy of Sciences.

[26]  C. Brayne,et al.  The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). , 2012, Current Alzheimer research.

[27]  Philip Scheltens,et al.  Discrepancy between subjective and objective sleep disturbances in early- and moderate-stage Alzheimer disease. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[28]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[29]  D. Bennett,et al.  Dementia from Alzheimer disease and mixed pathologies in the oldest old. , 2012, JAMA.

[30]  C. Huang,et al.  Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies , 2012, Internal medicine journal.

[31]  Jeffrey F. Thompson,et al.  Myelin Loss Associated With Neuroinflammation in Hypertensive Rats , 2012, Stroke.

[32]  L. Kappelle,et al.  Diabetes, hyperglycaemia, and acute ischaemic stroke , 2012, The Lancet Neurology.

[33]  Eric E. Smith,et al.  Cerebral microinfarcts: the invisible lesions , 2012, The Lancet Neurology.

[34]  Jacob K. Greenberg,et al.  Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy , 2011, Molecular Neurodegeneration.

[35]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[36]  P. Scheltens,et al.  2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? , 2011, Cerebrovascular Diseases.

[37]  C. Ayata,et al.  Cerebrovascular lesions induce transient β-amyloid deposition. , 2011, Brain : a journal of neurology.

[38]  B. Zlokovic,et al.  Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.

[39]  L. Launer,et al.  Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study , 2011, Annals of neurology.

[40]  R. Ransohoff.  Microglia and monocytes: 'tis plain the twain meet in the brain , 2011, Nature Neuroscience.

[41]  C. Jack,et al.  Ecology of the aging human brain. , 2011, Archives of neurology.

[42]  M. Burnett,et al.  Aging Causes Collateral Rarefaction and Increased Severity of Ischemic Injury in Multiple Tissues , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[43]  S. Leurgans,et al.  Microinfarct Pathology, Dementia, and Cognitive Systems , 2011, Stroke.

[44]  S. Minoshima,et al.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. , 2011, Archives of neurology.

[45]  R. Wetzel,et al.  Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice* , 2010, The Journal of Biological Chemistry.

[46]  J. Faber,et al.  Formation and maturation of the native cerebral collateral circulation. , 2010, Journal of molecular and cellular cardiology.

[47]  F. LaFerla,et al.  Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. , 2010, The American journal of pathology.

[48]  Xuming Dai,et al.  Endothelial Nitric Oxide Synthase Deficiency Causes Collateral Vessel Rarefaction and Impairs Activation of a Cell Cycle Gene Network During Arteriogenesis , 2010, Circulation research.

[49]  Guohong Li,et al.  Inflammatory mechanisms in ischemic stroke: role of inflammatory cells , 2010, Journal of leukocyte biology.

[50]  C. Rowe,et al.  11C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage , 2010, Neurology.

[51]  W. M. van der Flier,et al.  Patients With Alzheimer Disease With Multiple Microbleeds: Relation With Cerebrospinal Fluid Biomarkers and Cognition , 2009, Stroke.

[52]  S. Leurgans,et al.  The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.

[53]  et al.,et al.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2009, NeuroImage.

[54]  Suzanne Craft,et al.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.

[55]  Joanna M. Wardlaw,et al.  Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis , 2009, Neurobiology of Aging.

[56]  G. Zipfel,et al.  Cerebral Amyloid Angiopathy: Progressive Disruption of the Neurovascular Unit , 2009, Stroke.

[57]  Paul K Crane,et al.  Different patterns of cerebral injury in dementia with or without diabetes. , 2009, Archives of neurology.

[58]  D. Sviridov,et al.  Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque , 2008, Circulation research.

[59]  I. Shapira.  The Nun Study. , 2008, Journal of the American Dental Association.

[60]  Ping Zhou,et al.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.

[61]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[62]  Keith A. Johnson,et al.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.

[63]  J. Toutain,et al.  Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse , 2007, Experimental Neurology.

[64]  Frederick J. Hirsch,et al.  Summary and Next Steps , 2006 .

[65]  Y. Anzai,et al.  Blood-Brain Barrier Imaging and Therapeutic Potentials , 2006, Topics in magnetic resonance imaging : TMRI.

[66]  M. Hayden,et al.  The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease* , 2005, Journal of Biological Chemistry.

[67]  F. Jessen,et al.  APOA1 polymorphism influences risk for early‐onset nonfamiliar AD , 2005, Annals of neurology.

[68]  Jonathan Stone,et al.  Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[69]  D. Holtzman,et al.  Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model , 2005, The Journal of Neuroscience.

[70]  M. Ihara,et al.  White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion , 2004, Stroke.

[71]  Eric E. Smith,et al.  Amyloid Angiopathy–Related Vascular Cognitive Impairment , 2004, Stroke.

[72]  Kurt Bürki,et al.  Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis , 2004, Nature Neuroscience.

[73]  Peter J. Lenting,et al.  LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms , 2004, Neuron.

[74]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[75]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[76]  Soichiro Shimizu,et al.  Cerebral microbleeds in Alzheimer’s disease , 2003, Journal of Neurology.

[77]  C. Duyckaerts,et al.  Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia , 2003, Acta Neuropathologica.

[78]  Judianne Davis,et al.  Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells* , 2003, Journal of Biological Chemistry.

[79]  L. Launer,et al.  Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study , 2002, Neurology.

[80]  M. Graves,et al.  Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier , 2002, European journal of clinical investigation.

[81]  C. Pusey,et al.  Pathology of Vascular Disease , 2001 .

[82]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[83]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[84]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[85]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[86]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[87]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[88]  L. Lue,et al.  Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. , 1996, Journal of neuropathology and experimental neurology.

[89]  D. Snowdon,et al.  Trends in mortality in older women: findings from the Nun Study. , 1996, The journals of gerontology. Series B, Psychological sciences and social sciences.

[90]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[91]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[92]  W. Koroshetz,et al.  Research priority setting: a summary of the 2012 NINDS Stroke Planning Meeting Report. , 2013, Stroke.

[93]  E. Sokol.  National plan to address Alzheimer's disease offers hope for new home care and hospice provisions. , 2013, Caring : National Association for Home Care magazine.

[94]  C. Ayata,et al.  Genetic animal models of cerebral vasculopathies. , 2012, Progress in molecular biology and translational science.

[95]  S. Greenberg,et al.  Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy. , 2012, European neurological review.

[96]  D. Bennett,et al.  AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia , 2011 .

[97]  P. Mcgeer,et al.  Local neuroinflammation and the progression of Alzheimer’s disease , 2011, Journal of NeuroVirology.

[98]  R. Deane,et al.  LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. , 2004, Neuron.

[99]  Judianne Davis,et al.  Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. , 2003, The Journal of biological chemistry.

[100]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.